Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

High doses of finasteride cause cell growth and tumors in mice.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Spironolactone did not make hair thinner in women with excess hair growth.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Acne significantly affects both physical health and mental well-being.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

150 kHz electromagnetic radiation might help improve PCOS in rats.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.